I’m The Only One With Genius DNA 28

I’m The Only One With Genius DNA chapter 28

Scientific Supernova (2)

==================

“I made optic nerves with reverse differentiated stem cells and treated retinal denatured mice with them.”

Ryu Young-joon told Ji Kwang-man.

“There’s no performance report yet.”

Ji Kwang-man said while looking at Ryu’s data.

“Because I didn’t raise the draft.”

“Then you should’ve posted a draft, why would you come to me first and tell me?”

“I wanted to tell you something in advance.”

Ji Kwang-man leaned his fat body against the chair. He looked at Ryu Young-joon with suspicious eyes.

“What’s that?”

“When I hold 90 percent of the royalties of the reverse differentiated stem cell patents, I have the key to all subsequent research and the bottom line.”

“So?”

“My studies are scheduled to be published in Science. Not only inversely differentiated stem cells, but also optic nerve therapy. I don’t know if I’m talking about stem cells, but I’d be surprised if I could open my eyes to the blind.”

“······.”

“Now things have changed a bit. When the paper is published, the scientific and medical circles will not be the only ones paying attention. Investors will be interested. And our shareholders will also be interested. They used to focus more on sales, net income, and dividends than on which drugs were developed, but this time they’ll be different.”

“Hmm.”

“And you’ll be upset to know that there’s only one senior researcher holding the reverse differentiated stem cell royalty. You’d be shocked to learn that even if you patented this much, you wouldn’t lose any of your royalty.”

Ryu Young-joon said.

“You’re the one who approves my contracts and patent applications, so you’ll be held accountable.”

“So what?”

“Hold hands with me.”

Only Ji-kwang stared at Ryu Young-joon.

“What are you suggesting?”

“We will sell some of the 80 percent stake allocated to the Life Creation Department to headquarters. Then, you will be the best manager who encouraged talented researchers to research and at the same time produced good results and maximized shareholders’ share.”

“How much do you want for the sale?”

“Not money, give me a stake in Eisen.”

Ji-kwang’s eyes shook.

He took a few sips of hot tea and said,

“How much?”

“You have to give a 1 percent stake in Eisen’s headquarters per 5 percent royalty on reverse differentiated stem cell source technology. How much would you like to buy?”

“That’s crazy. Do you think you’d make such a deal?”

“Why can’t you?”

“That 80 percent stake is company public money. It’s not your personal money. Shareholders may be upset, but it’s the amount of money they’ll eventually reinvest in the company. We can give the shareholders that return.”

“That’s the premise that I’m producing results on that 80% share of the budget.”

Ji-kwang’s eyes got bigger.

“······. What are you talking about? You’re an employee of Eisen! Are you saying that you’re going to intentionally strike?”

“Who will judge whether I’m in a strike or if I’m working hard and I’m not getting any results?”

“What?”

“Is there anyone in the world who knows more about reverse differentiation stem cells and neurodifferentiation and nerve transplant therapy than I do?”

“······.”

“And if I go between shareholders, will they really hate it? The value of my name will be different after the special paper is published in Science. It’s not a bad choice for the director to give me shares and invite me among the executives. It’s helpful for the development of the company, and shareholders will like it. And if you give me royalties. We can be win-win.”

Only Ji-kwang bit his lips.

Ryu Young-joon said.

“I’ll be more generous. If you give me a 4 percent stake in the company, I’ll give you a 30 percent royalty. It’s up to you to hand it out to the shareholders or not.”

“Four percent is like the head of a research institute. And in cash, it’s a trillion!”

“Considering the value of a patent, it’s a very cheap sale. It’s a fundamental technology, so I don’t know if it’s going to be a lot of money, but if we put together the stem cell therapy market that starts here, it’s going to be thousands of trillion.”

“Do you think I can give you that much stock, whether it’s cheap or expensive?”

“The director has to think about it. I personally think it’s a realistic amount.”

“Can I say that you want to participate in Eisen’s management in acting like this?”

“Can I say that you want to participate in Eisen’s management to act like this now?”

“That’s right.”

Ryu Young-joon replied firmly.

“I must have misjudged you. I thought you weren’t interested in internal politics and management. You said you wanted to study stem cells.

“For me, the study was everything. But when I didn’t pay attention to it, they used the researchers’ achievements for something strange. I don’t think I’m going to be used like that anymore.”

“Stop.”

Only Jigwang waved his hand.

“Dr. Ryu, the contract you brought, it’s just a piece of paper. I haven’t signed it yet, and we can discuss this again and deal with the law. Do you really want that way?”

“That’s unexpected. I trusted the director and completed retinal degeneration treatment in the optic nerve differentiation and animal model, and he doesn’t keep his promise?”

“I think I’ve told you before, I’m a businessman. Only actions does it come to my income. In this case, I think it’s more profitable to break your promise and listen to what’s behind your back. I don’t want to be dragged around by Dr. Ryu anymore. Whether you go to Pfizer or not, it’s up to you.”

“Well, it’s not going to be that easy. I’ve already said I’d get 80 percent.”

“To whom?”

Knock, knock, knock.

Someone knocked on the door outside.

“Director, this is Secretary Joo.”

The secretary of the headquarters came in.

“What’s going on? I’m in the middle of a meeting.”

“Hey, hey, hey, hey. A reporter wants to have an interview.”

“Reporter?”

“CNN reporter.”

“CNN?”

Only Ji-kwang tilted his head.

“Not SBS or KBS, but CNN? CNN in the U.S.? Why all of a sudden? Who are you interviewing?”

“Director and Dr. Ryu Young-joon.”

Boom.

I could hear something falling down in my chest. I feel suffocated all of a sudden.

Something’s wrong.

Ryu Young-joon was clearing his throat with a sound of, um, sound next to him.

“I didn’t expect you to come already. The news is really fast. We haven’t even made it to the Science Special yet.”

“What did you do?”

“I had an interview with the Science Journal.”

“····· what?”

“I’ve told you the whole truth. And I only talked about good things to the company. I didn’t say anything bad about taking away liver cancer treatments from small and medium-sized companies and getting them to extract spinach from a senior researcher who wanted to quit. Don’t worry too much. That’s all I’ve said about what you promised me in a more humanistic way.”

Ryu Young-joon smiled.

I got goosebumps on Jigwangman’s shoulders.

I understood the situation at once.

Ji Kwang-man. He has been here for more than 30 years, experiencing all sorts of prenatal struggles, and defeating all sorts of psychopaths and crazy seeds without tomorrow.

And I’ve never felt this fear in a person before.

That smile looked like a devil’s smile.

“It’s the deal I suggested. Don’t forget. It’s 4 percent.”

Ryu Young-joon said.

***

Research papers published in Science should meet the 4,500-character limit.

However, Ryu Young-joon’s thesis was more than 10,000 characters in total.

Samuel, editor of Science, just ignored the rules and put them all away. It is one of the most prestigious papers in the history of the journal Science. What’s the big deal?

Samuel grinned and read the summary of the paper again.

Stem cells have great potential to repair damaged nerves and organs, but are limited by the great limitations of needing fertilized eggs. In this paper, we have acquired the technology to create stem cells by reverse differentiating human normal somatic cells. It also succeeded in differentiating stem cells back into myocardial and optic nerve cells. Among them, optic nerve cells were injected into the observatory area of the mouse on the retina-modified end stage to confirm that vision was restored.>

It’s a very short, data description-filled summary with a 100 percent integration rate.

Every sentence is like an axe beating the scientific community.

“Nature, you bastards. You didn’t know this, did you? As of today, the top journal of biology is Science.”

Samuel laughed pleasedly as he uploaded the manuscript.

Samuel laughed pleasedly as he uploaded the manuscript.

Throughout the history of Science, there’s probably nothing comparable to this other than the Genome Project paper.

And there is something more important than this legendary paper.

Biologist, Dr. Ryu Young-joon’s excavation.

He is a young man who is only 28 years old.

Korea has a strange culture of getting one year old together when the year changes, so it is said that it is 30 in its own country, but it is 28 in American age anyway.

James Watson, who revealed the structure of DNA, was also an elite who graduated from college at the age of 16 and received a doctorate at the age of 24.

What will this genius create in the decades left to come?

In an interview, Ryu Young-joon made remarks that focused the attention of pharmaceutical workers and scientists around the world.

This is the killing point.

The last part of the interview Jessie brought.

Dr. Liu, do you have any plans to go into the clinical world to treat actual patients with optic nerves made from reverse differentiated stem cells?

Jessie asked.

“Of course, Eisen will provide clinical support. And we’re not going to stop there.”

Then what?

“The reverse differentiated stem cells have the potential to differentiate into every tissue and every nerve. And we have the ability to make that possibility a reality.”

Ryu Young-joon said.

“In the next few years, we plan to root out all neurological disorders, such as Parkinson, spinal cord damage, stroke, electroencephalopathy, dementia, multiple sclerosis, Lou Gehrig and Lefthom, based on reverse differentiated stem cells.”

It wasn’t in the script for the interview, but at the moment Jesse almost screamed.

– That’s ······ Is that possible?

“It won’t be long. I promise you for sure here. I’m planning a big pharmaceutical project to eliminate all kinds of neurological diseases. Just as there are no more people suffering from smallpox in the 21st century, no neurological disease will ever make a person suffer. Human medicine has already taken the next step, and all humans have the right not to get sick. You have the right to be happy while keeping your body safe.”

Ryu Young-joon said.

“The object of our declaration of war is “neurological disease” itself, and the first of which is optic neuropathy. I promise. For the next half year. Within exactly that time, we will complete the technique to treat all patients with optic nerve damage.”

I felt suffocated.

Unknown emotions filled Jessie’s heart.

She was a doctor at MIT and a researcher. Research takes years, it’s hard, it’s hard, it’s boring.

At some point she gave up her research.

I found it interesting to introduce other scientists’ work. Since becoming an editor of Science, I have never missed the life of a first-line researcher.

I was happy reading the new papers. Watching the discovery of knowledge that was unknown to mankind one by one quenched intellectual thirst and enjoyed it.

That’s what her science was like.

While living as an editor, the science Jessie knows so far has been the object of wonder and entertainment.

But I realized today.

Science may be an object of emotion.

The future that Ryu Young-joon draws is not a mysterious and fun future.

He is not a scientist who seeks intellectual exaltation and enjoyment in finding beautiful and thrilling truths and informing editors and the public.

As a first-term researcher, he was close to a warrior.

The point where he struggled was not a new technology of high-tech science or an excavation of new scientific knowledge, but a battlefield to fight disease.

A soldier of science who fights on the front lines of the oldest battlefield in human history, the confrontation between mankind and disease.

He understood his position as it was, and he had faith in it.

– That······ Is the research funding supported by Eisen?

Jessie asked.

“Of course, Eisen is the best pharmaceutical company in the world. We also support researchers. Shareholders didn’t even take a stake in the reverse differentiated stem cells. It was just to reinvest in research.”

Are you sure?

“Yes, on the condition that this study succeeds, I’ve decided to just give myself 10 percent of the royalties of the counter-differentiated stem cells, and 80 percent of them will be processed with the department’s budget, and then give me the right to approve. It was a consideration to allow me to do all the research I wanted to do.”

-Waah!

“Even the remaining 10 percent went mostly to first-line researchers. Shareholders didn’t have any shares in the royalties.”

– Wow······ That’s amazing. That’s how much you trust Dr. Liu?

“And that’s how much I’m looking forward to this research. Eisen is that kind of place. Rather than squeezing sweet water from the work, it greatly appreciates the first-line researcher and encourages him to complete his next study.”

That’s great. Competitive pharmaceutical companies like Pfizer and Johnson & Johnson must be nervous and worried.

“You don’t have to do that.”

Why?

Why?

“There may be people near them who suffer from severe neurological disorders, or families who suffer from them. The patient is not a stranger. Anyone can be paralyzed from the lower half of the body in an accident. It doesn’t matter if I develop it, whether Pfizer develops it, or Roche develops it. I just need to give my patients hope. Scientists should pursue human convenience and well-being, not money or honor.”

I see. Do Eisen’s management think so, too?

“That’s what you’d think. I gave up all of my shareholders’ shares and fully supported me and the researchers.”

I’m The Only One With Genius DNA chapter 28

|

ToC

|